Filter announcements
Loading...
Incorporated in 2004, Sakar Healthcare Ltd is in the business of manufacturing Research & Development of Pharmaceutical products
Sakar Healthcare received 14 new oncology product approvals in EU, UK, and Canada with 7 partners. This expands cancer treatment coverage, positioning the company to boost top-line sales.
Sakar Healthcare Limited has informed the Exchange about Copy of Newspaper Publication
Sakar Healthcare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 22, 2026
Sakar Healthcare delivered strong Q1 FY27 financial results: Revenue at INR72.97 Cr (up 38% YoY), EBITDA at INR21.25 Cr (up 67% YoY) with 29% margins, and PAT at INR10.28 Cr (up 120% YoY). The company is rapidly transforming into an oncology-led export powerhouse. It has 55 oncology molecules developed and...
Sakar Healthcare Limited has informed the Exchange about Copy of Newspaper Publication